Glen­mark hit with warn­ing let­ter over pro­ce­dures, qual­i­ty con­trol is­sues at In­dia man­u­fac­tur­ing plant

The gener­ics pro­duc­er Glen­mark Phar­ma­ceu­ti­cals has been hand­ed a warn­ing let­ter by US reg­u­la­tors.

The let­ter, which was sent to the man­u­fac­tur­er on Nov. 22 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER